FUNDING: This study was funded by Mazta Farma
BMI requirements for GLP-1 medications are based on obesity treatment guidelines, FDA-approved indications, and clinical trials evaluating safety and effectiveness
Till date, there are only few reports on efficacy of liposomal glutathione and more needs to be explored.[] CONCLUSION As of now, no conclusive evidence can be drawn in favor of glutathione for the treatment of dermatologic disorders
1,2 Intramembranous ossification primarily occurs in the skull as well as a portion of the clavicle, where mesenchymal stem cells (MSCs) directly differentiate into osteoblasts ( Figure 1 )
Glucagon-like Peptide-1 (GLP-1) Agonists in Clinical Practice This section will give in-depth information about the existing local and systemic options in the current treatment paradigm for all the potential indications, in which most pharmaceutical companies are actively evaluating their inhibitors
Tirzepatide (marketed as Zepbound for weight management and Mounjaro for type 2 diabetes in the UK) is a dual GIP/GLP-1 receptor agonist that has shown similar side effect profiles in clinical trials, including reports of dizziness